Synovus Financial’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $31.4K | Hold |
11,796
| – | – | ﹤0.01% | 936 |
|
|
2025
Q2 | $35K | Hold |
11,796
| – | – | ﹤0.01% | 906 |
|
|
2025
Q1 | $38.2K | Hold |
11,796
| – | – | ﹤0.01% | 891 |
|
|
2024
Q4 | $46.6K | Hold |
11,796
| – | – | ﹤0.01% | 868 |
|
|
2024
Q3 | $91.2K | Hold |
11,796
| – | – | ﹤0.01% | 898 |
|
|
2024
Q2 | $60.6K | Hold |
11,796
| – | – | ﹤0.01% | 835 |
|
|
2024
Q1 | $95.9K | Hold |
11,796
| – | – | ﹤0.01% | 831 |
|
|
2023
Q4 | $47.2K | Hold |
11,796
| – | – | ﹤0.01% | 819 |
|
|
2023
Q3 | $48.6K | Hold |
11,796
| – | – | ﹤0.01% | 829 |
|
|
2023
Q2 | $70.1K | Hold |
11,796
| – | – | ﹤0.01% | 826 |
|
|
2023
Q1 | $40.7K | Hold |
11,796
| – | – | ﹤0.01% | 817 |
|
|
2022
Q4 | $41.4K | Hold |
11,796
| – | – | ﹤0.01% | 849 |
|
|
2022
Q3 | $43K | Hold |
11,796
| – | – | ﹤0.01% | 835 |
|
|
2022
Q2 | $66K | Hold |
11,796
| – | – | ﹤0.01% | 828 |
|
|
2022
Q1 | $102K | Hold |
11,796
| – | – | ﹤0.01% | 830 |
|
|
2021
Q4 | $131K | Hold |
11,796
| – | – | ﹤0.01% | 841 |
|
|
2021
Q3 | $153K | Hold |
11,796
| – | – | ﹤0.01% | 819 |
|
|
2021
Q2 | $195K | Hold |
11,796
| – | – | ﹤0.01% | 808 |
|
|
2021
Q1 | $203K | Hold |
11,796
| – | – | ﹤0.01% | 720 |
|
|
2020
Q4 | $185K | Hold |
11,796
| – | – | ﹤0.01% | 738 |
|
|
2020
Q3 | $225K | Hold |
11,796
| – | – | ﹤0.01% | 658 |
|
|
2020
Q2 | $162K | Hold |
11,796
| – | – | ﹤0.01% | 692 |
|
|
2020
Q1 | $125K | Sell |
11,796
-5,876
| -33% | -$95.6K | ﹤0.01% | 873 |
|
|
2019
Q4 | $330K | Hold |
17,672
| – | – | ﹤0.01% | 569 |
|
|
2019
Q3 | $185K | Hold |
17,672
| – | – | ﹤0.01% | 666 |
|
|
2019
Q2 | $134K | Hold |
17,672
| – | – | ﹤0.01% | 664 |
|
|
2019
Q1 | $195K | Hold |
17,672
| – | – | ﹤0.01% | 591 |
|
|
2018
Q4 | $90K | Hold |
17,672
| – | – | ﹤0.01% | 694 |
|
|
2018
Q3 | $56K | Hold |
17,672
| – | – | ﹤0.01% | 812 |
|
|
2018
Q2 | $79K | Hold |
17,672
| – | – | ﹤0.01% | 718 |
|
|
2018
Q1 | $95K | Hold |
17,672
| – | – | ﹤0.01% | 685 |
|
|
2017
Q4 | $70K | Hold |
17,672
| – | – | ﹤0.01% | 574 |
|
|
2017
Q3 | $77K | Hold |
17,672
| – | – | ﹤0.01% | 565 |
|
|
2017
Q2 | $83K | Hold |
17,672
| – | – | ﹤0.01% | 635 |
|
|
2017
Q1 | $291K | Hold |
17,672
| – | – | 0.01% | 460 |
|
|
2016
Q4 | $179K | Hold |
17,672
| – | – | ﹤0.01% | 533 |
|
|
2016
Q3 | $238K | Hold |
17,672
| – | – | 0.01% | 465 |
|
|
2016
Q2 | $370K | Hold |
17,672
| – | – | 0.01% | 381 |
|
|
2016
Q1 | $167K | Hold |
17,672
| – | – | ﹤0.01% | 501 |
|
|
2015
Q4 | $192K | Hold |
17,672
| – | – | ﹤0.01% | 456 |
|
|
2015
Q3 | $264K | Buy |
+17,672
| New | +$309K | 0.01% | 399 |
|
Other funds holding XBIT
RC
Synovus Financial's XBIT Position: Q3 2025 in Review
Synovus Financial held its XBiotech (XBIT) position steady in Q3 2025 at 11,796 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #936.
Synovus Financial first reported a position in XBIT in Q3 2015 and has held it in 41 quarters since. The position peaked at $370K in Q2 2016. 48 funds tracked by Wall St. Rank hold XBIT as of Q3 2025.
- Synovus Financial held 11,796 shares of XBiotech worth $31.4K as of Q3 2025.
- Synovus Financial left its XBiotech share count unchanged in Q3 2025.
- XBiotech made up ﹤0.01% of Synovus Financial's portfolio in Q3 2025, its #936 holding.
- Synovus Financial first reported a position in XBiotech in Q3 2015 and has held it in 41 quarters since.
- Synovus Financial's XBiotech position peaked at $370K in Q2 2016.
- 48 funds tracked by Wall St. Rank held XBiotech as of Q3 2025.
Based on Synovus Financial's 13F filing for Q3 2025, filed 7 Nov 2025.